EichorEICHOR
Location: Bangalore Synced from ClinicalTrials.gov · August 09, 2026

Clinical studies recruiting near Bangalore

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart
Phase 3 · CON-51013, Bangalore, Karnataka · Colorado Prevention Center · NCT06024746Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT05755386This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Pfizer · NCT06758401Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)
Phase 1 · Health Care Global Enterprises Ltd. · Ichnos Sciences SA · NCT05862012Study of WAL0921 in Patients With Glomerular Kidney Diseases
Phase 2 · MS Ramaiah Medical College and Hospitals · Walden Biosciences · NCT06466135A Planned Study at Multiple Sites is Being Done to Compare the Results of Two Types of Trifocal Toric Intraocular Lenses
NA · Netradhama Superspeciality Eye Hospital · Biotech Healthcare Holding Gmbh · NCT07232615A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Phase 3 · Eli Lilly and Company · NCT07369011'Glycogen Storage Diseases (GSDs) in Indian Children- Establishing an Indian GSD (I-GSD) Registry'
Phase N/A · Institute of Liver and Biliary Sciences, India · NCT06396546A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
Phase 3 · Bristol-Myers Squibb · NCT06976216EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Phase 3 · Manipal Hospital · Boehringer Ingelheim · NCT06531824Erythropoietin for Neonatal Encephalopathy in LMIC (EMBRACE Trial)
Phase 3 · Bangalore Medical College · Imperial College London · NCT05395195A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropath
Phase 3 · Manipal Hospital Bangalore · Biogen · NCT06962800Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of
Phase 3 · Research Site · AstraZeneca · NCT06921785A Study to Learn More About How Safe Darolutamide is and How Well it Works Under Real World Conditions When Taken in Add
Phase 4 · Bangalore Medical College and Research Institute (BMCRI) - V · Bayer · NCT05348876A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Sta
Phase 3 · Bristol-Myers Squibb · NCT06561386A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Livi
Phase 2 · Novo Nordisk A/S · NCT06717698An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Phase 3 · Research Site · AstraZeneca · NCT05952557A Study to Learn About Somatrogon in Patients With Pediatric Growth Hormone Deficiency (p GHD) in India.
Phase N/A · Pfizer · NCT06587035A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants Wi
Phase 3 · Research Site · AstraZeneca · NCT05211895AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obst
Phase 3 · Novo Nordisk A/S · NCT07571005A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treat
Phase 3 · Research Site · AstraZeneca · NCT06764875A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KR
Phase 3 · Eli Lilly and Company · NCT06119581A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Year
Phase 3 · Sanofi · NCT07285460A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
Phase 2 · Medstar Speciality Hospital · Eli Lilly and Company · NCT07219173Evaluating a Nitric Oxide Generator, Nebivolol as a Disease Modifier in Patients With Diabetic Neuropathy.
Phase 2/Phase 3 · St John's Medical College Hospital · St. John's Research Institute · NCT06201611Study of 2 Medicines (Aztreonam and Avibactam) Compared to Best Available Therapy for Serious Gram-negative Infections
Phase 2 · RajaRajeswari Medical College and Hospital · Pfizer · NCT05639647Global Trial in APG2575 for Patients With CLL/SLL
Phase 3 · Ascentage Investigative Site · Ascentage Pharma Group Inc. · NCT06104566A Study of Tirzepatide (LY3298176) in Adult Participants in India With Either Type 2 Diabetes Mellitus or Obesity
Phase 4 · Eli Lilly and Company · NCT07438444Alloplastic Total Temporomandibular Joint (TMJ) Replacement Registry
Phase N/A · Sri Shankara Cancer Hospital and Research Center · AO Innovation Translation Center · NCT03991728Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Dee
Phase 3 · Anthos Investigative Site 2311 · Anthos Therapeutics, Inc. · NCT05712200
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.